ZURA a penny stock has catalysts- an FDA action is soon upcoming and an insider bought a lot
more shares. The 120-minute chart shows a solid trend up since earnings March 28th. This
pre-revenue company beat earnings with less cash burn than expected. Another earnings
report is about a month away. Price has settled to the support of the longest EMA line.
I see an opportunity here for a long trade toward the earnings in a month. The longer black RSI
line above the 50 level while the shorter green line shows the oversold undervalued condition
for an entry.
more shares. The 120-minute chart shows a solid trend up since earnings March 28th. This
pre-revenue company beat earnings with less cash burn than expected. Another earnings
report is about a month away. Price has settled to the support of the longest EMA line.
I see an opportunity here for a long trade toward the earnings in a month. The longer black RSI
line above the 50 level while the shorter green line shows the oversold undervalued condition
for an entry.
Note
Price moved down a bit. Holding a full position and patient.Note
Reversed the move down and more or less sideways.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.